Saturday, August 26, 2023
GE Healthcare has recently launched the Vscan Air SL, a wireless handheld ultrasound imaging system designed for swift cardiac and vascular assessments directly at the point of care. This cutting-edge addition to the Vscan product range incorporates GE Healthcare's proprietary SignalMax and XDclear technologies, enhancing imaging performance by offering superior penetration, resolution, and sensitivity through its single crystal transducer technology.
Given the prevalence of cardiovascular disease and its tendency to manifest as emergencies, rapid diagnosis and treatment are crucial. The Vscan Air SL is meticulously crafted to empower clinicians in efficiently obtaining and examining clear cardiac and vascular images at the patient's side. This agile approach not only streamlines workflows but also eases the strain on traditional radiology resources, expediting critical care decisions when time is of the essence.
The device's compact, wireless nature makes it effortlessly portable, granting clinicians the ability to conduct comprehensive whole-body scans and securely review images. Furthermore, with the inclusion of the Vscan Air + Digital Tools, practitioners can access a suite of user-friendly solutions that optimize workflow, encompassing secure collaboration, image management, and device administration features.
GE Healthcare, emphasizes how the Vscan Air SL empowers clinicians to swiftly assess cardiac conditions, further enriching their ultrasound technology portfolio to enhance on-the-spot clinical decisions. This innovation underscores the commitment to holistic patient care delivery, ultimately enhancing patient outcomes.
This breakthrough has placed over 50,000 Vscan systems in the hands of clinicians, positively impacting the care of more than an estimated 100 million patients globally. Building on this legacy, the Vscan Air SL and CL continue GE Healthcare's tradition of pioneering technology, simplifying the acquisition of high-quality ultrasound images.
The Vscan Air SL is currently available in select European and Asian countries, as well as Australia and New Zealand. In the United States, the device has received 510(k) clearance from the FDA and is anticipated to be available in the current quarter.
Source: businesswire.com
